T1	Participants 71 101	patients with advanced cancer:
T2	Participants 203 219	advanced cancer.
T3	Participants 582 699	Patients with advanced cancer with a fatigue score of â‰¥ 4 out of 10 on the Edmonton Symptom Assessment Scale (ESAS)
T4	Participants 1044 1097	RESULTS One hundred forty-one patients were evaluable
